sutent 25 mg capsulas
pfizer venezuela, s.a. - sunitinib - capsulas - 25 mg
sutent 50 mg capsulas
pfizer venezuela, s.a. - sunitinib - capsulas - 50 mg
vibramicina 100 mg capsulas
pfizer venezuela, s.a. - doxiciclina - capsulas - 100 mg
terramicina 250 mg 250 mg capsula
pfizer s.a. - capsula - por capsula; clorhidrato de oxitetraciclina 270.000000 mg; - oxitetraciclina
efexor xr 150 mg
pfizer inc. [us] united states - venlafaxina clorhidrato 169.70 mg equivalente a 150 mg de venlafaxina base - capsulas de liberacion prolongada - cada capsula contiene: venlafaxina clorhidrato 169.70 mg equivalente a 150 mg de venlafaxina base
efexor® xr 75mg
pfizer inc [us] united states - venlafaxina clorhidrato 84.85 mg equivalente a 75 mg de venlafaxina base - capsulas de liberaciÓn prolongada - cada cápsula contiene: venlafaxina clorhidrato 84.85 mg equivalente a 75 mg de venlafaxina base
diflucan 200 mg capsulas
pfizer venezuela, s.a. - fluconazol - capsulas - 200 mg
pemetrexed pfizer (previously pemetrexed hospira)
pfizer europe ma eeig - pemetrexed disodium, pemetrexed disodium hemipentahydrate - carcinoma, non-small-cell lung; mesothelioma - agentes antineoplásicos - malignant pleural mesotheliomapemetrexed pfizer in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed pfizer in combination with cisplatin is indicated for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology. pemetrexed pfizer is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy. pemetrexed pfizer is indicated as monotherapy for the second-line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology.
voriconazol pfizer 200 mg polvo para solucion para perfusion efg
pfizer, s.l. - voriconazol - excipientes: sulfobutileter-b-ciclodextrina de sodio - antimicÓticos para uso sistÉmico - derivados triazólicos - voriconazol
remifentanilo pfizer 5 mg polvo para concentrado para solucion inyectable y para perfusion efg
pfizer s.l. - remifentanilo hidrocloruro - polvo para concentrado para solucion inyectable y para perfusion - 5 mg - remifentanilo hidrocloruro 5 mg - remifentanilo